UBS O'Connor’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

UBS O'Connor’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-170,000	Closed	-$4.1M	–	591
2014 Q2	$4.1M	Buy	+170,000	New	+$1.77M	0.03%	228

UBS O'Connor's IDIX Position: Q3 2014 in Review

UBS O'Connor sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 170,000 shares — an estimated $4.1M sold.

UBS O'Connor first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $4.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

UBS O'Connor reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
UBS O'Connor sold 170,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $4.1M.
UBS O'Connor first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
UBS O'Connor's IDENIX PHARMACEUTICALS INC position peaked at $4.1M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on UBS O'Connor's 13F filing for Q3 2014, filed 14 Nov 2014.